Dr.Kanimozhi M

Dr.Kanimozhi M

Assistant Professor
Department : Pharmacology

Introduction:

I am a passionate medical teacher with a strong commitment and dedication to academic excellence. Having graduated from the Institute of National Importance, my skills encompass research, clinical pharmacology, and patient care, complemented by a passion for advancing medical knowledge.

Educational Qualifications:

Degree Year Name of College & University Registration number with
date of registration
Name of State Medical council
MBBS 2014 Kanniyakumari Govt Medical College The Tamil Nadu Dr. MGR Medical University 108475 (14.10.2014) Tamil Nadu Medical Council
MD 2024 All India Institute of Medical Sciences Rishikesh 108475 (08.02.2024) Tamil Nadu Medical Council

Details of Teaching experience till date:

Designation Department Institution From To Total
Tutor Pharmacology All India Institute of Medical Sciences Rishikesh 23.01.2021 22.01.2024 3 Years
Senior Resident Pharmacology SRM Medical College Hospital & Research Centre 12.02.2024 26.04.2025 1 Year 2 Months
Assistant Professor Pharmacology SRM Medical College Hospital & Research Centre 28.04.2025 Till Date
Research & Publications :
  • M Kanimozhi 1, Manisha Bisht 1,*, Sikha Morang 1, Surabhi Thapliyal 1, Manbir S Bassan 1, Shailendra Handu 1 Impact of Dapagliflozin Adjunctive Therapy on the Progression of Chronic Kidney Disease in Patients with Type 2 Diabetes and Chronic Kidney Disease Stages 2–5 Sultan Qaboos Univ Med J . 2024 Aug 29;24(3):317–326. doi: 10.18295/squmj.12.2023.093
  • Subhash Samanta 1 , Manisha Bisht 1 , M Kanimozhi 1 , Niraj Kumar 2 , Shailendra S Handu1 Association of depression with disease duration, quality of life and adherence in Parkinson's disease: A cross sectional study J Family Med Prim Care . 2023 Jul;12(7):1406-1411. doi: 10.4103/jfmpc.jfmpc_2288_22. Epub 2023 Jul 14.
  • Akash Agnihotri, Kanimozhi Senduran M., Subhash Samanta, Manjunath Bidarolli, A short review on atogepant: recently approved first oral calcitonin gene-related peptide receptor antagonist August 2022International Journal of Basic & Clinical Pharmacology 11(5):532 DOI:10.18203/2319-2003.ijbcp20222154
  • M Kanimozhi 1 , Manisha Bisht 2 , Ravikant 3 , Arkapal Bandyopadhyay 4 , Manisha Naithani 5 , Shailendra Handu 6 Pleiotropic effect of teneligliptin versus glimepiride add-on therapy on hs-CRP and cardiorenal parameters in Indian type 2 diabetes patients: An open-labeled randomized controlled trial Perspect Clin Res. 2025 Jan-Mar;16(1):14-22. doi: 10.4103/picr.picr_265_23. Epub 2024 Jul 10.
  • Subhash Samanta1, Niraj Kumar​2, M. Kanimozhi1, Manisha Bisht1, Ravi Gupta3 Effect of motor, non-motor clinical features including sleep quality, and prescription pattern on adherence to antiparkinsonian medications in Parkinson’s disease Original Article 15 (3); 448-454 doi:10.25259/JNRP_585_2023